VCM
GHDX

Versant Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Versant Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10
Closed – – 1722
2019
Q3 		$0 Buy
+10
New +$687 ﹤0.01% 1720

Versant Capital Management's GHDX Position: Q4 2019 in Review

Versant Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 10 shares.

Versant Capital Management first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Versant Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Versant Capital Management sold 10 Genomic Health, Inc. shares in Q4 2019.
  • Versant Capital Management first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
  • Versant Capital Management's Genomic Health, Inc. position peaked at $0 in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Versant Capital Management's 13F filing for Q4 2019, filed 28 Jan 2020.